Ten-year follow-up results of perioperative chemotherapy with doxorubicin and ifosfamide for high-grade soft-tissue sarcoma of the extremities: Japan Clinical Oncology Group study JCOG0304

Kazuhiro Tanaka(Oita University), Yukihide Iwamoto(Kyushu University), Hirohisa Katagiri(Shizuoka Cancer Center), Akihito Nagano(Gifu University), Makoto Emori, Kunihiro Asanuma(Mie University), Haruhiko Fukuda(Japan Clinical Cancer Research Organization), Koji Hatano(Niigata Cancer Center Hospital), Akira Kawai(GTx (United States)), Junki Mizusawa(Japan Clinical Cancer Research Organization), Munenori Watanuki(Tohoku University Hospital), Hiroaki Hiraga, Toru Hiruma, Hiroyuki Tsuchiya(Kanazawa University), Tsukasa Yonemoto, Robert Nakayama(Keio University), Ryohei Yokoyama(National Hospital Organization Kyushu Cancer Center), Satoshi Abe(Tottori University), Yoshihiro Matsumoto(Jikei University Kashiwa hospital), Hideki Yoshikawa(Amita Health), Yukihiro Yoshida(University of Tokyo Hospital), Keisuke Ae, Takeshi Morii(Kyorin University), Takeshi Okamoto(Japanese Foundation For Cancer Research), Norifumi Naka(University of the Witwatersrand), Toshifumi Ozaki(Okayama University)
BMC Cancer
September 6, 2019
Cited by 27


Related Papers